Lidocain Pharmarissano

Lidocaine Hydrochloride, the active ingredient in Lidocain Pharmarissano, is a local anesthetic presented as a sterile solution for intradermal use. It provides temporary loss of sensation for minor dermatological procedures and superficial surgical interventions. GNH USA supplies Lidocain Pharmarissano as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Hydrochloride is used to provide local anesthesia for procedures affecting the skin and superficial tissues.

Minor dermatological procedures: provides local anesthesia to reduce pain during skin biopsies, excisions, or laser treatments. Superficial surgical interventions: enables temporary loss of sensation for minor incisions, suturing, or excisional procedures. Diagnostic skin testing: allows intradermal administration for allergy or tuberculin testing with minimal discomfort.

Lidocain Pharmarissano may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Pain or burning at the injection site - Redness or erythema around the area - Swelling or mild edema - Itching or pruritus - Dizziness or light‑headedness - Nausea or mild gastrointestinal upset

Serious or Rare Side Effects: - Central nervous system toxicity (e.g., seizures, confusion) - Cardiovascular effects (e.g., arrhythmias, hypotension) - Allergic reactions (e.g., rash, urticaria, anaphylaxis) - Methemoglobinemia - Respiratory depression - Persistent numbness beyond the expected duration

When using Lidocain Pharmarissano, consider the following safety measures.

Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. Dose limitation: adhere to recommended maximum dose to avoid systemic toxicity. Cardiovascular monitoring: observe patients with existing heart disease or conduction abnormalities. Pediatric use: adjust dose carefully based on weight and age. Pregnancy and lactation: use only if the potential benefit justifies the unknown risk. Store below 25°C: keep in the original pack, protect from moisture.

Lidocain Pharmarissano can interact with other medicines; awareness of the level of interaction helps manage risk.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may potentiate cardiotoxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can increase plasma lidocaine levels. - Concurrent use of other local anesthetics: additive toxicity risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance bradycardia when combined. - General anesthetics (e.g., propofol, volatile agents): may increase central nervous system depression. - Diuretics (e.g., furosemide): may alter plasma protein binding and affect lidocaine concentration.